Methylphenidate Hydrochloride Chewable Tablets recall
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ…
Why was Methylphenidate Hydrochloride Chewable Tablets recalled?
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
lot# 25910009, Exp 01/2023
- Product
- Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ…
- Recalling firm
- RISING PHARMACEUTICALS
- Quantity
- 2220 100-count bottles
- Distribution
- Nationwide in the USA
- Recall date
- March 2, 2022
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)